Av action presentation

  • Published on
    23-Aug-2014

  • View
    139

  • Download
    7

Embed Size (px)

DESCRIPTION

 

Transcript

<ul><li> PHARAONIA PHARMACEUTICALS </li> <li> EXCELSA ESCITALOPRAM 2010 </li> <li> EXCELSAEXCELSA Escitalopram </li> <li> EXCELSAEXCELSA </li> <li> EXCELSAEXCELSA </li> <li> EXCELSAEXCELSA </li> <li> EXCELSAEXCELSA </li> <li> EXCELSAEXCELSA </li> <li> EXCELSAEXCELSA </li> <li> LANZAPINE has characteristic significant efficacy concerning rate of discontinuation. </li> <li> LANZAPINE Mono-therapy Improves depression In patients with Bipolar I Disorder. </li> <li> LANZAPINE Found to increase BDNF In patients with Schizophrenia. </li> </ul>